Merck Kgaa (MKGAF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MKGAF | UTHR | NBIX | ||
| Company | Merck Kgaa | United Therapeutic | Neurocrine Bioscienc | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 147.7035 | 509.55 | 130.32 | ||
| High | 153.7080 | 527.14 | 133.25 | ||
| Low | 146.0010 | 506.00 | 130.32 | ||
| Latest | 153.7080 | 513.82 | 132.38 | ||
| Change | -0.6120 | +9.92 | +0.13 | ||
| % Change | -0.40% | +1.97% | +0.10% | ||
| Volume | 900 | 747,600 | 1,025,200 | ||
| 20-Day Average Volume | 455 | 395,430 | 1,319,565 | ||
| Previous Close | 154.3200 | 503.90 | 132.25 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 150.2715 | 484.44 | 132.81 | ||
| 20-Day Raw Stochastic | 77.52% | 67.88% | 49.52% | ||
| 20-Day Relative Strength | 53.24 | 59.45 | 46.75 | ||
| Weighted Alpha | +12.32 | +55.44 | +11.52 | ||
| Today's Opinion | 96% Buy | 88% Buy | 88% Sell | ||
| Previous Opinion | 96% Buy | 88% Buy | 72% Sell | ||
| Last Month's Opinion | 100% Buy | 40% Buy | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.67% since 02/23/26 | +8.28% since 02/23/26 | +3.12% since 02/23/26 | ||
| Low | 145.5090 on 02/24/26 | 466.56 on 02/24/26 | 128.03 on 02/24/26 | ||
| High | 156.0350 on 02/27/26 | 537.19 on 02/25/26 | 133.25 on 03/02/26 | ||
| 1-Month | |||||
| %Chg | +1.91% since 02/02/26 | +8.17% since 02/02/26 | -3.81% since 02/02/26 | ||
| Low | 140.3530 on 02/05/26 | 464.44 on 02/11/26 | 122.14 on 02/12/26 | ||
| High | 157.5800 on 02/13/26 | 537.19 on 02/25/26 | 142.82 on 02/10/26 | ||
| 3-Month | |||||
| %Chg | +9.83% since 12/02/25 | +8.37% since 12/02/25 | -13.18% since 12/02/25 | ||
| Low | 134.0000 on 12/10/25 | 455.63 on 01/20/26 | 122.14 on 02/12/26 | ||
| High | 159.3380 on 01/27/26 | 537.19 on 02/25/26 | 160.18 on 12/08/25 | ||
| 6-Month | |||||
| %Chg | +19.66% since 09/02/25 | +26.93% since 09/02/25 | -6.72% since 09/02/25 | ||
| Low | 122.8500 on 09/15/25 | 375.61 on 09/05/25 | 122.14 on 02/12/26 | ||
| High | 159.3380 on 01/27/26 | 537.19 on 02/25/26 | 160.18 on 12/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 21,873,870 | 22,084,924 | 13,273,005 | ||
| Shares Outstanding, K | 129,240 | 43,828 | 100,363 | ||
| Annual Sales | 22,720,720,000 | 2,877,400,000 | 2,860,500,000 | ||
| Annual Net Income | 3,056,420,000 | 1,195,100,000 | 478,600,000 | ||
| Last Quarter Sales | 5,763,570,000 | 799,500,000 | 805,500,000 | ||
| Last Quarter Net Income | 653,680,000 | 338,700,000 | 153,700,000 | ||
| 60-Month Beta | 0.96 | 0.85 | 0.31 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.51 on 08/01/24 | 7.70 on 02/25/26 | 1.88 on 02/11/26 | ||
| Latest Earnings Date | 11/14/24 | 04/29/26 | 05/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 23.55 | 18.06 | 28.69 | ||